Canadian Agency for Drugs and Technologies in Health. (2015). Pharmacoeconomic review report Tiotropium bromide monohydrate and olodaterol hydrochloride (Inspiolto respimat) for oral inhalation. Canadian Agency for Drugs and Technologies in Health.
Cita Chicago Style (17a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Tiotropium Bromide Monohydrate and Olodaterol Hydrochloride (Inspiolto Respimat) for Oral Inhalation. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2015.
Cita MLA (9a ed.)Canadian Agency for Drugs and Technologies in Health. Pharmacoeconomic Review Report Tiotropium Bromide Monohydrate and Olodaterol Hydrochloride (Inspiolto Respimat) for Oral Inhalation. Canadian Agency for Drugs and Technologies in Health, 2015.
